Stratagene Announces Second Quarter 2006 Earnings Release Date and Conference Call

Stratagene Corporation (NASDAQ:STGN), today announced
that it will release second quarter financial results on Tuesday,
August 8, 2006 after the market close. The Company will also host a
conference call and webcast on Tuesday, August 8, 2006 at 1:30 p.m.
Pacific Time to discuss the Company's second quarter results, outlook
for the remainder of 2006, and current corporate developments. The
dial-in number for the conference call is 800-257-2101 for domestic
participants and 303-262-2143 for international participants.
   A taped replay of the conference call will also be available
beginning approximately one hour after the call's conclusion and will
remain available for 7 days. It can be accessed by dialing
800-405-2236 for domestic callers and 303-590-3000 for international
callers, using the passcode 11066634#. To access the live webcast of
the call, go to Stratagene's website at http://www.stratagene.com and
click on the Investors icon. An archived webcast will also be
available at http://www.stratagene.com.

   About Stratagene Corporation

   Stratagene is a developer, manufacturer and marketer of
specialized life science research and diagnostic products. The
Company's life science research unit supports advances in science by
inventing, manufacturing and distributing products that simplify,
accelerate and improve research. These products are used throughout
the academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery and
toxicology. The Company's diagnostic unit develops and manufactures
products for urinalysis, and high quality automated instrument and
reagent systems that use blood samples to test for more than 1,000
different allergies and autoimmune disorders. In addition, by
combining its expertise in diagnostics and molecular biology, as well
as its experience with FDA regulatory procedures, the Company is
pursuing opportunities to expand its product portfolio to include
molecular diagnostic kits and instrumentation. More information is
available at www.stratagene.com.